AIC
SMMT icon

AWM Investment Company’s Summit Therapeutics SMMT Stock Holding History

AWM Investment Company’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-800,001
Closed -$1.4M – 119
2023
Q1 		$1.4M Buy
800,001
+500,001
+167% +$1.36M 0.19% 82
2022
Q4 		$1.27M Buy
+300,000
New +$546K 0.18% 78
2015
Q3 		– Sell
-42,693
Closed -$451K – 124
2015
Q2 		$451K Buy
+42,693
New +$484K 0.06% 120

Other funds holding SMMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

AWM Investment Company's SMMT Position: Q2 2023 in Review

AWM Investment Company sold out of Summit Therapeutics (SMMT) in Q2 2023, closing a stake of 800,001 shares — an estimated $1.4M sold.

AWM Investment Company first reported a position in SMMT in Q2 2015 and held it in 3 quarters. The position peaked at $1.4M in Q1 2023. 100 funds tracked by Wall St. Rank hold SMMT as of Q2 2023.

  • AWM Investment Company reported no remaining Summit Therapeutics position as of Q2 2023 after selling out during the quarter.
  • AWM Investment Company sold 800,001 Summit Therapeutics shares in Q2 2023, an estimated $1.4M.
  • AWM Investment Company first reported a position in Summit Therapeutics in Q2 2015 and held it in 3 quarters.
  • AWM Investment Company's Summit Therapeutics position peaked at $1.4M in Q1 2023.
  • 100 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2023.

Based on AWM Investment Company's 13F filing for Q2 2023, filed 11 Aug 2023.